
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Perhaps instead of warning HIVers that they are at risk for AIDS-related opportunistic infections if their CD4-cell counts are low and their viral loads are high, it may be more accurate to simply say they're at risk for dangerous infections of all sorts, say researchers in a study in the Journal of Acquired Immune Deficiency Syndromes. And, surprisingly, the risks for some ailments -- like liver disease, heart disease, and non-AIDS-defining cancers -- actually begin to rise long before OI risks are present, they report. A CD4-cell count below 200 dramatically raises risks for AIDS-related opportunistic infections, according to international guidelines. But a CD4-cell count above 200 was linked with severe non-AIDS-defining illnesses, according to an analysis of nearly 1,300 French HIV patients. With regard to non-AIDS-related cancers, risks increased when CD4-cell counts dropped below the relatively high 500-cell threshold. The two-year analysis also showed that serious non-AIDS-related diseases -- and deaths caused by them -- were much more common than AIDS-related ailments and deaths. In light of their findings, the researchers say successful antiretroviral therapy is vital in preventing the onset of not only AIDS and HIV-related OIs but other serious diseases. "Optimization and permanent continuation of long-term antiretroviral therapy in HIV-infected patients is the best strategy to prevent or reduce the occurrence of non-AIDS severe morbidity," they write.
From our Sponsors
Most Popular
Plus: Featured Video